Combined pancreatic islet and kidney transplantation in a child with unstable type 1 diabetes and end-stage renal disease

American Journal of Transplantation

Volumn 13, Issue 8, 2013, Pages 2207-2210

  Benedict, K A ^a   Moassesfar, S ^a   Adi, S ^a   Gitelman, S E ^a   Brennan, J L ^a   McEnhill, M ^a   Stock, P G ^a   Portale, A A ^a   Posselt, A M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Islet transplantation; kidney transplantation; pediatric; renal disease; type I diabetes

Indexed keywords

DACLIZUMAB; GLUCOSE; INSULIN; INSULIN GLARGINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ARTICLE; CASE REPORT; CHILD; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY PANCREAS TRANSPLANTATION; MALE; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL;

ISLET TRANSPLANTATION; KIDNEY TRANSPLANTATION; PEDIATRIC; RENAL DISEASE; TYPE I DIABETES;

ADULT; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; PROGNOSIS;

EID: 84881375797     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12323     Document Type: Article

References (14)

1. Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629-637.
2. Ricordi C, Lacy PE, Rinke EH, et al. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413-420.
3. Szot GL, Lee MR, Tavakol MM, et al. Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease. Transplantation 2009; 88: 753-756.
4. Posselt AM, Szot GL, Frassetto LA, et al. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppression protocols based on T-cell adhesion or costimulation blockade. Transplantation 2010; 90: 1595-1601.
5. Baidal DA, Faradji RN, Messinger S, et al. Early metabolic markers of islet allograft dysfunction. Transplantation 2009; 87: 689-697.
6. Sis B, Mengel M, Haas M., et al. Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464-471.
7. D'Apolito M, Du X, Zong H, et al. Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest 2010; 120: 203-213.
8. Eidemak I, Feldt-Rasmussen B, Kanstrup IL, et al. Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 1995; 38: 565-572.
9. Sechi LA, Catena C, Zingaro L, et al. Abnormalities of glucose metabolism in patients with early renal failure. Diabetes 2002; 51: 1226-1232.
10. Alejandro R, Barton FB, Hering BJ, et al. Collaborative Islet Transplant Registry Investigators. 2008 Update from the Collaborative Islet Transplant Registry. Transplantation 2008; 86: 1783-1788.
11. Jamiolkowski RM, Guo LY, Li YR, et al. Islet transplantation in type I diabetes mellitus. Yale J Biol Med 2012; 85: 37-43, Epub Mar 29, 2012.
12. Smith RM, Gale EA., Survival of the fittest? Natural selection in islet transplantation Transplantation 2005; 79: 1301-1313.
13. Cantarovich D, De Amicis S, Aki A, et al. Post-transplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcome. Am J Transplant 2011; 11: 2737-2746.
14. Campbell PM, Salam A, Ryan EA, et al. Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. Am J Transplant 2007; 7: 1242-1248.